Antibodies | Time to diagnosis | ||
---|---|---|---|
Time <7 years n = 51 | Time ≥ 7 years n = 52 | p-value | |
RF n (%) | 15 (29) | 9 (18) | 0.179 |
CCP2 n (%) | 15 (27) | 10 (20) | 0.298 |
CEP1 n (%) | 11 (21) | 4 (8) | 0.056 |
REP1 n (%) | 2 (4) | 0 (0) | 0.157 |
cFib n (%) | 13 (25) | 6 (12) | 0.092 |
Fib n (%) | 1 (2) | 1 (2) | 0.978 |
cVim n (%) | 4 (10) | 1 (3) | 0.204 |
Vim n (%) | 3 (6) | 1 (2) | 0.278 |
CPP3 n (%) | 1 (2) | 1 (2) | 0.989 |
RPP3 n (%) | 3 (6) | 2 (4) | 0.663 |
CPP5 n (%) | 2 (4) | 3 (6) | 0.631 |
RPP5 n (%) | 0 (0) | 2 (4) | 0.149 |
RgpB n (%) | 2 (4) | 1 (2) | 0.569 |
RgpB quartiles | |||
1 (<1280) | 25 (48) | 26 (51) | 0.571 |
2 (≥1280) | 17 (33) | 12 (24) | |
3 (≥2560) | 8 (15) | 12 (24) | |
4 (≥5120) | 2 (4) | 1 (2) | |
RgpB (u/ml), median (IQR) | 1280 (713–1946) | 1174 (468–2560) | 0.449 |